Cytogenetic as an important tool for diagnosis and prognosis for patients with hypocellular primary myelodysplastic syndrome

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Corrêa De Souza, Daiane ^a   De Souza Fernandez, Cecília ^b   Camargo, Adriana ^c   Apa, Alexandre Gustavo ^a   Sobral Da Costa, Elaine ^d   Bouzas, Luis Fernando ^a   Abdelhay, Eliana ^a   De Souza Fernandez, Teresa ^a  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^c Hemostasis and Thrombosis Laboratory   (Brazil)

^d FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; LENALIDOMIDE; THALIDOMIDE;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CLINICAL DECISION MAKING; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HYPOCELLULAR PRIMARY MYELODYSPLASTIC SYNDROME; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PROGNOSIS; ADOLESCENT; AGED; BRAZIL; CHILD; CHROMOSOME DISORDERS; GENETIC SCREENING; GENETICS; INFANT; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CYTOGENETIC ANALYSIS; FEMALE; GENETIC TESTING; HUMANS; INFANT; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84907279806     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/542395     Document Type: Article

References (40)

1. Nimer S. D., Myelodysplastic syndromes. Blood 2008 111 10 4841 4851 10.1182/blood-2007-08-078139 2-s2.0-46749151451
2. Niemeyer C. M., Baumann I., Myelodysplastic syndrome in children and adolescents. Seminars in Hematology 2008 45 1 60 70 10.1053/j.seminhematol.2007.10.006 2-s2.0-37548998653
3. Elghetany M. T., Myelodysplastic syndromes in children: a critical review of issues in the diagnosis and classification of 887 cases from 13 published series. Archives of Pathology & Laboratory Medicine 2007 131 7 1110 1116 2-s2.0-34447300991
4. Tuzuner N., Cox C., Rowe J. M., Watrous D., Bennett J. M., Hypocellular myelodysplastic syndromes (MDS): new proposals. British Journal of Haematology 1995 91 3 612 617 10.1111/j.1365-2141.1995.tb05356.x 2-s2.0-0028784950
5. Tomonaga M., Nagai K., Hypocellular myelodysplastic syndromes and hypocellular acute myeloid leukemia: relationship to aplastic anemia. The Myelodysplastic Syndromes: Pathobiology and Clinical Management 2002 New York, NY, USA Marcel Dekker 121 138
6. Yue G., Hao S., Fadare O., Baker S., Pozdnyakova O., Galili N., Woda B. A., Raza A., Wang S. A., Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome. Leukemia Research 2008 32 4 553 558 10.1016/j.leukres.2007.08.006 2-s2.0-39149083040
7. Haase D., Cytogenetic features in myelodysplastic syndromes. Annals of Hematology 2008 87 7 515 526 10.1007/s00277-008-0483-y 2-s2.0-44449158040
8. Kawankar N., Jijina F., Ghosh K., Vundinti B. R., Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes. Cancer Epidemiology 2011 35 4 e1 e5 10.1016/j.canep.2010.11.009 2-s2.0-79960567835
9. Bacher U., Kern W., Alpermann T., Schnittger S., Haferlach C., Haferlach T., Prognoses of MDS subtypes RARS, RCMD and RCMD-RS are comparable but cytogenetics separates a subgroup with inferior clinical course. Leukemia Research 2012 36 7 826 831 10.1016/j.leukres.2012.04.003 2-s2.0-84862313893
10. Fernandez T. S., Ornellas M. H., Otero L., Tabak D., Abdelhay E., Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia. Leukemia Research 2000 24 10 839 848 10.1016/S0145-2126(00)00056-4 2-s2.0-0033847694
11. Marisavljević D., Čemerikić V., Rolović Z., Bošković D., Čolović M., Hypocellular myelodysplastic syndromes: clinical and biological significance. Medical Oncology 2005 22 2 169 175 10.1385/MO:22:2:169 2-s2.0-22344449046
12. Huang T. C., Ko B. S., Tang J. L., Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies. Leukemia 2008 22 3 544 550 10.1038/sj.leu.2405076 2-s2.0-40749160472
13. Qu S., Xu Z., Zhang Y., Qin T., Zhang T., Cui R., Xiao Z., Impacts of cytogenetic categories in the Revised International Prognostic Scoring System on the prognosis of primary myelodysplastic syndromes: results of a single-center study. Leukemia & Lymphoma 2012 53 5 940 946 10.3109/10428194.2011.634049 2-s2.0-84860002247
14. Wang H., Wang X. Q., Xu X. P., Lin G., Cytogenetic evolution correlates with poor prognosis in myelodysplastic syndrome. Cancer Genetics and Cytogenetics 2010 196 2 159 166 10.1016/j.cancergencyto.2009.09.015 2-s2.0-71649097591
15. Greenberg P., Cox C., Le Beau M. M., International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997 89 6 2079 2088 2-s2.0-0032006112
16. Bennett J. M., Catovsky D., Daniel M. T., Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982 51 2 189 199 10.1111/j.1365-2141.1982.tb08475.x 2-s2.0-0019952276
17. Hasle H., Niemeyer C. M., Chessells J. M., Baumann I., Bennett J. M., Kerndrup G., Head D. R., A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003 17 2 277 282 10.1038/sj.leu.2402765 2-s2.0-0037325661
18. Shaffer L. G., McGowan-Jordan J., Schmid M., ISCN: An International System for Human Cytogenetic Nomenclature 2013 Basel, Switzerland S. Karger
19. Ebert B. L., Pretz J., Bosco J., Chang C. Y., Tamayo P., Galili N., Raza A., Root D. E., Attar E., Ellis S. R., Golub T. R., Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008 451 7176 335 339 10.1038/nature06494 2-s2.0-38349088899
20. Kaneko H., Misawa S., Horiike S., Nakai H., Kashima K., TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities. Blood 1995 85 8 2189 2193 2-s2.0-0028955808
21. Silveira C. G. T., Oliveira F. M., Valera E. T., Ikoma M. R. V., Borgonovo T., Cavalli I. J., Tone L. G., Rogatto S. R., New recurrent deletions in the PPAR γ and TP53 genes are associated with childhood myelodysplastic syndrome. Leukemia Research 2009 33 1 19 27 10.1016/j.leukres.2008.07.013 2-s2.0-55049115055
22. Sebaa A., Ades L., Baran-Marzack F., Mozziconacci M., Penther D., Dobbelstein S., Stamatoullas A., Récher C., Prebet T., Moulessehoul S., Fenaux P., Eclache V., Incidence of 17p deletions and TP53 mutation in myelodysplastic syndrome and acute myeloid leukemia with 5q deletion. Genes Chromosomes and Cancer 2012 51 12 1086 1092 10.1002/gcc.21993 2-s2.0-84867230100
23. Alharbi R. A., Pettengell R., Pandha H. S., Morgan R., The role of HOX genes in normal hematopoiesis and acute leukemia. Leukemia 2013 27 5 1000 1008 10.1038/leu.2012.356 2-s2.0-84877587301
24. INK4Agenes in pediatric primary myelodysplastic syndrome. Leukemia & Lymphoma 2010 51 10 1887 1894 10.3109/10428194.2010.505820 2-s2.0-77957741934
25. Alfaro R., Pérez-Granero Á., Durán M. A., Besalduch J., Rosell J., Bernués M., dup(1)(q21q32) as a sole cytogenetic event is associated to a leukemic transformation in Myelodysplastic Syndromes. Leukemia Research 2008 32 1 159 161 10.1016/j.leukres.2007.03.033 2-s2.0-36148950992
26. Mani M., Carrasco D. E., Yunyu Z., Takada K., Gatt M. E., Dutta-Simmons J., Ikeda H., Diaz-Griffero F., Pena-Cruz V., Bertagnolli M., Myeroff L. L., Markowitz S. D., Anderson K. C., Carrasco D. R., BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Research 2009 69 19 7577 7586 10.1158/0008-5472.CAN-09-0773 2-s2.0-70350225573
27. Eguchi M., Eguchi-Ishimae M., Greaves M., Molecular pathogenesis of MLL-associated leukemias. International Journal of Hematology 2005 82 1 9 20 10.1532/IJH97.05042 2-s2.0-27244458612
28. Fernandez T. D. S., Silva M. L. M., De Souza J., De Paula M. T. M., Abdelhay E., C-MYC amplification in a case of progression from MDS to AML (M2). Cancer Genetics and Cytogenetics 1996 86 2 183 184 10.1016/0165-4608(95)00191-3 2-s2.0-0030075559
29. Greenberg P. L., Tuechler H., Schanz J., Sanz G., Garcia-Manero G., Solé F., Bennett J. M., Bowen D., Fenaux P., Dreyfus F., Kantarjian H., Kuendgen A., Levis A., Malcovati L., Cazzola M., Cermak J., Fonatsch C., Le Beau M. M., Slovak M. L., Krieger O., Luebbert M., Maciejewski J., Magalhaes S. M. M., Miyazaki Y., Pfeilstöcker M., Sekeres M., Sperr W. R., Stauder R., Tauro S., Valent P., Vallespi T., Van De Loosdrecht A. A., Germing U., Haase D., Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012 120 12 2454 2465 10.1182/blood-2012-03-420489 2-s2.0-84866621729
30. Rodrigues E. F., de Souza D. C., Camargo A., de Cássia Tavares R., Bouzas L. F., Ornellas M. H., de Souza Fernandez T., Cytogenetic biclonality in a child with hypocellular primary myelodysplastic syndrome. Cancer Genetics and Cytogenetics 2007 178 1 70 72 10.1016/j.cancergencyto.2007.05.025 2-s2.0-34548660774
31. de Souza Fernandez T., Ornellas M. H., de Cássia Tavares R., Otero L., Diamond H. R., Bouzas L. F., Tabak D., Abdelhay E., Hyperdiploid karyotype in a child with hypocellular primary myelodysplastic syndrome. European Journal of Haematology 2003 71 5 399 401 10.1034/j.1600-0609.2003.00150.x 2-s2.0-0142217316
32. Glaubach T., Robinson L. J., Corey S. J., Pediatric myelodysplastic syndromes: they do exist! Journal of Pediatric Hematology Oncology 2014 36 1 1 7
33. Tong W., Quintás-Cardama A., Kadia T., Borthakur G., Jabbour E., Ravandi F., Faderl S., Wierda W., Pierce S., Shan J., Bueso-Ramos C., Kantarjian H., Garcia-Manero G., Predicting survival of patients with hypocellular myelodysplastic syndrome: development of a disease-specific prognostic score system. Cancer 2012 118 18 4462 4470 10.1002/cncr.27420 2-s2.0-84862559115
34. Bacher U., Haferlach C., Kröger N., Schnittger S., Kern W., Wiedemann B., Zander A. R., Haferlach T., Diagnostic tools in the indications for allogeneic stem cell transplantation in myelodysplastic syndromes. Biology of Blood and Marrow Transplantation 2010 16 1 1 11 10.1016/j.bbmt.2009.08.007 2-s2.0-72649096494
35. Anderson J. E., Allogeneic bone marrow transplantation in myelodysplastic syndrome. The Myelodysplastic Syndromes: Pathobiology and Clinical management 2002 New York, NY, USA Marcel Dekker 435 464
36. Alessandrino E. P., Porta M. G. D., Malcovati L., Jackson C. H., Pascutto C., Bacigalupo A., Teresa van Lint M., Falda M., Bernardi M., Onida F., Guidi S., Iori A. P., Cerretti R., Marenco P., Pioltelli P., Angelucci E., Oneto R., Ripamonti F., Rambaldi A., Bosi A., Cazzola M., Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome. American Journal of Hematology 2013 88 7 581 588 10.1002/ajh.23458 2-s2.0-84879407728
37. Makishima H., Rataul M., Gondek L. P., Huh J., Cook J. R., Theil K. S., Sekeres M. A., Kuczkowski E., O'Keefe C., Maciejewski J. P., FISH and SNP-A karyotyping in myelodysplastic syndromes: improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q). Leukemia Research 2010 34 4 447 453 10.1016/j.leukres.2009.08.023 2-s2.0-76749133549
38. de Souza D. C., de Figueiredo A. F., Mkrtchyan H., A yet unreported der(11)t(6;11)(p21;q21) included in a complex karyotype of a refractory anemia with ring sideroblasts and poor prognosis. Blood Cells, Molecules and Diseases 2014 53 1-2 91 93 10.1016/j.bcmd.2013.12.006
39. Otrock Z. K., Tiu R. V., Maciejewski J. P., Sekeres M. A., The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication? Expert Review of Hematology 2013 6 1 59 68 10.1586/ehm.12.67 2-s2.0-84873388120
40. Gisselsson D., Heim S., Mitelman F., Cytogenetic methods. Cancer Cytogenetics 2009 3rd Wiley-Blackwell 9 16